Bifunctional anti/prooxidant potential of metallothionenin: redox signaling of copper binding and release.
Metallothioneins (MTs) are cysteine-rich metal-binding proteins that exert cytoprotection during metal exposure and oxidative stress. The roles of MT in copper (Cu) binding and release and modulation of redox cycling are unresolved. We hypothesized that Cu-binding to MT renders Cu redox inactive, but that oxidation of free thiols critical for metal binding can reduce MT/Cu interactions and potentiate Cu redox cycling. Overexpression of MT in cells by cadmium pretreatment or ectopic overexpression by gene transfer confers protection from Cu-dependent lipid oxidation and cytotoxicity. Using a chemically defined model system (Cu/ascorbate/H2O2) to study Cu/MT interactions, we observed that MT inhibited Cu-dependent oxidation of luminol. In the absence of H2O2, MT blocked Cu-dependent ascorbyl radical production with a stoichiometry corresponding to Cu/MT ratios < or = 12. In the presence of H2O2, Cu-dependent hydroxyl radical formation was inhibited only up to Cu/MT ratios < or = 6. Using low-temperature EPR of free Cu2+ to assess Cu/MT physical interactions, we observed that the maximal amount of Cu1+ bound to MT corresponded to 12 molar equivalents of Cu/MT with Cu and ascorbate alone and was reduced in the presence of H2O2. 2,2'-Dithiodipyridine titration of MT SH-groups revealed a 50% decrease after H2O2, which could be regenerated by dihydrolipoic acid (DHLA). DHLA regeneration of thiols in MT was accompanied by restoration of MT's ability to inhibit Cu-dependent oxidation of ascorbate. Thus, optimum ability of MT to inhibit Cu-redox cycling directly correlates with its ability to bind Cu. Some of this Cu, however, appears releasable following oxidation of the thiolate metal-binding clusters. We speculate that redox-dependent release of Cu from MT serves both as a mechanism for physiological delivery of Cu to specific target proteins, as well as potentiation of cellular damage during oxidative stress.
Department of Environmental & Occupational Health, School of Public Health, University of Pittsburgh, Pennsylvania 15238, USA. fabs+@pitt edu
J P
JP
Fabisiak
L L
LL
Pearce
G G
GG
Borisenko
Y Y
YY
Tyhurina
V A
VA
Tyurin
J
J
Razzack
J S
JS
Lazo
B R
BR
Pitt
V E
VE
Kagan
D000818:Animals; D000975:Antioxidants / Q000378:metabolism* / Q000494:pharmacology; D002104:Cadmium / Q000494:pharmacology; D002470:Cell Survival; D003300:Copper / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology* / Q000633:toxicity; D004578:Electron Spin Resonance Spectroscopy; D004730:Endothelium, Vascular / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver; D008165:Luminol / Q000378:metabolism; D008668:Metallothionein / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D016877:Oxidants / Q000378:metabolism* / Q000494:pharmacology; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D011817:Rabbits; D013438:Sulfhydryl Compounds / Q000378:metabolism; D008063:Thioctic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D014162:Transfection
D000975:Antioxidants; D016877:Oxidants; D013438:Sulfhydryl Compounds; D002104:Cadmium; D008165:Luminol; D008063:Thioctic Acid; D003300:Copper; C015144:dihydrolipoic acid; D008668:Metallothionein; D006861:Hydrogen Peroxide